Vasoactive Intestinal Peptide Receptor 1 (VIPR1) (C-Term) Peptide
VIPR1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all VIPR1 products
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- WRRWHLQGVL GWNPKYRHPS GGSNGATCST QVSMLTRVSP GARRSSSFQA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- VIPR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
- Background
-
This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: II, HVR1, RDC1, V1RG, VIPR, VIRG, VAPC1, VPAC1, VPAC1R, VIP-R-1, VPCAP1R, PACAP-R2, PACAP-R-2
Protein Size: 492 - Gene ID
- 7433
- NCBI Accession
- NM_001251882, NP_001238811
-
You are here:
